Literature DB >> 22490327

Charybdotoxin and margatoxin acting on the human voltage-gated potassium channel hKv1.3 and its H399N mutant: an experimental and computational comparison.

Azadeh Nikouee1, Morteza Khabiri, Stephan Grissmer, Rüdiger Ettrich.   

Abstract

The effect of the pore-blocking peptides charybdotoxin and margatoxin, both scorpion toxins, on currents through human voltage-gated hK(v)1.3 wild-type and hK(v)1.3_H399N mutant potassium channels was characterized by the whole-cell patch clamp technique. In the mutant channels, both toxins hardly blocked current through the channels, although they did prevent C-type inactivation by slowing down the current decay during depolarization. Molecular dynamics simulations suggested that the fast current decay in the mutant channel was a consequence of amino acid reorientations behind the selectivity filter and indicated that the rigidity-flexibility in that region played a key role in its interactions with scorpion toxins. A channel with a slightly more flexible selectivity filter region exhibits distinct interactions with scorpion toxins. Our studies suggest that the toxin-channel interactions might partially restore rigidity in the selectivity filter and thereby prevent the structural rearrangements associated with C-type inactivation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22490327     DOI: 10.1021/jp2102463

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  6 in total

1.  Scorpion toxins prefer salt solutions.

Authors:  Azadeh Nikouee; Morteza Khabiri; Lukasz Cwiklik
Journal:  J Mol Model       Date:  2015-10-16       Impact factor: 1.810

2.  Margatoxin-bound quantum dots as a novel inhibitor of the voltage-gated ion channel Kv1.3.

Authors:  Austin B Schwartz; Anshika Kapur; Wentao Wang; Zhenbo Huang; Erminia Fardone; Goutam Palui; Hedi Mattoussi; Debra Ann Fadool
Journal:  J Neurochem       Date:  2016-12-12       Impact factor: 5.372

3.  Olfactory bulb-targeted quantum dot (QD) bioconjugate and Kv1.3 blocking peptide improve metabolic health in obese male mice.

Authors:  Austin B Schwartz; Anshika Kapur; Zhenbo Huang; Raveendra Anangi; John M Spear; Scott Stagg; Erminia Fardone; Zolan Dekan; Jens T Rosenberg; Samuel C Grant; Glenn F King; Hedi Mattoussi; Debra Ann Fadool
Journal:  J Neurochem       Date:  2020-10-20       Impact factor: 5.372

4.  Synaptic disruption and CREB-regulated transcription are restored by K+ channel blockers in ALS.

Authors:  Alberto Catanese; Sandeep Rajkumar; Daniel Sommer; Dennis Freisem; Alexander Wirth; Amr Aly; David Massa-López; Andrea Olivieri; Federica Torelli; Valentin Ioannidis; Joanna Lipecka; Ida Chiara Guerrera; Daniel Zytnicki; Albert Ludolph; Edor Kabashi; Medhanie A Mulaw; Francesco Roselli; Tobias M Böckers
Journal:  EMBO Mol Med       Date:  2021-06-14       Impact factor: 12.137

5.  Recombinant expression of margatoxin and agitoxin-2 in Pichia pastoris: an efficient method for production of KV1.3 channel blockers.

Authors:  Raveendra Anangi; Shyny Koshy; Redwan Huq; Christine Beeton; Woei-Jer Chuang; Glenn F King
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

Review 6.  Peptide Inhibitors of Kv1.5: An Option for the Treatment of Atrial Fibrillation.

Authors:  Jesús Borrego; Adam Feher; Norbert Jost; Gyorgy Panyi; Zoltan Varga; Ferenc Papp
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.